Mirabegron in Parkinson Disease and Impaired Cognition

Clinical trial NCT02536976 · COMPLETED

Trial details

NCT number: NCT02536976
Sponsor: HealthPartners Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson Disease Overactive Bladder Impaired Cognition

Start date: 2015-12-01
Primary completion: 2018-08-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.